vents on the calendar for us. We are very active in seeking high quality partners and BioTrinity offers a highly efficient and effective way of doing that. In addition to the showcased companies, the partnering system works well and the high quality of the panels adds to overall breadth of the conference."
Dina Chaya, Venture Partner, NeoMed, said: "BioTrinity offers investors a great forum to meet exciting new companies and also to network with our peers. The invitation-only investor dinner is a unique event and the quality of the panels is second to none."
OBN is a not-for-profit business network which provides comprehensive support for its member biotech and medtech companies in the Oxford and South-East England biocluster and the rest of the UK. Our activities can be summarised as networking, partnering, group purchasing, and fundraising advice. Through its delivery of Europe's fastest growing biopartnering and investment conference, BioTrinity, OBN generates more R&D-company-to-investor interactions than anyone else in Europe. OBN is sponsored by Shire, as Corporate Patron, and Corporate Sponsors MEPC, Manches LLP, James Cowper, George James, Interea International, SRG, FOCUS Insurance, World Courier and Citigate Dewe Rogerson as well as by its extensive membership of R&D companies and other companies across the entire life sciences industry ecosystem. OBN counts more than 200 companies amongst its membership, which is growing over 40% per year.
For further information on OBN and its activities, please visit: http://www.obn.org.uk
ContactsPage: 1 2 3 Related biology technology :1
Jon Rees, CEO
Citigate Dewe Rogerson
Chris Gardner/Nina Enegren
. CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 20112
. Another Successful Year at Divine Skin3
. Another Top 10 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 4
. The MedZilla Report for April 2010 - Pharma Layoffs Drop Below 400 in March; Health Care Adds Another 27,000 Jobs5
. Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation and the Addition of Board Member, Mark Spilker6
. Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services7
. The MedZilla Report for August 2009 -- Health Care Grows Another 28,000 While Hospitals And Insurers Feel Painful Pinch8
. The first DFG research centers to be funded for another 4 years9
. GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years10
. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services11
. Cephalon Reports Another Strong Quarter